(19)
(11) EP 2 493 464 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.06.2018 Bulletin 2018/26

(45) Mention of the grant of the patent:
18.04.2018 Bulletin 2018/16

(21) Application number: 10827568.6

(22) Date of filing: 29.10.2010
(51) International Patent Classification (IPC): 
A61K 31/10(2006.01)
A61K 31/43(2006.01)
A61K 45/06(2006.01)
A61K 9/00(2006.01)
A01N 31/00(2006.01)
C12N 1/18(2006.01)
C12N 1/38(2006.01)
C12P 7/56(2006.01)
A61K 31/437(2006.01)
A61K 31/431(2006.01)
A61K 39/085(2006.01)
A61P 31/04(2006.01)
A01N 41/10(2006.01)
C12N 1/20(2006.01)
C12P 7/06(2006.01)
(86) International application number:
PCT/US2010/054837
(87) International publication number:
WO 2011/053848 (05.05.2011 Gazette 2011/18)

(54)

METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS

METHYLSULFONYLMETHAN (MSM) ZUR BEHANDLUNG WIRKSTOFFRESISTENTER MIKROORGANISMEN

MÉTHYLSULFONYLMÉTHANE (MSM) POUR LE TRAITEMENT DE MICRO-ORGANISMES RÉSISTANTS AUX MÉDICAMENTS


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 06.11.2009 US 259098 P
12.01.2010 US 294437 P
03.11.2009 US 257751 P
30.10.2009 US 256935 P

(43) Date of publication of application:
05.09.2012 Bulletin 2012/36

(73) Proprietor: Biogenic Innovations, LLC
Vancouver, WA 98660 (US)

(72) Inventors:
  • BENJAMIN, Rodney
    Camas, WA 98607 (US)
  • VARELMAN, Jeffrey
    Moyie Springs, ID 83845 (US)
  • KELLER, Anthony
    Ashland, OR 97520 (US)

(74) Representative: Walton, Seán Malcolm et al
Mewburn Ellis LLP
City Tower 40 Basinghall Street London EC2V 5DE
City Tower 40 Basinghall Street London EC2V 5DE (GB)


(56) References cited: : 
EP-A2- 2 251 003
WO-A2-2005/115546
US-A- 3 654 165
US-A- 4 616 039
US-A1- 2008 038 219
WO-A1-2010/126376
WO-A2-2006/129149
US-A- 4 559 329
US-A1- 2006 229 262
   
  • KULSHRESTHA D C ET AL: "Inhibition of bacteria by some volatile and non volatile compounds associated with milk. III. Staphylococcus aureus", J.MILK FOOD TECHNOL. 1974, vol. 37, no. 11, 1974, pages 545-550, XP008160756,
  • BORODINA ET AL.: 'Dimethylsulfone as a growth substrate for novel methylotrophic species of Hyphomicrobium and Arthrobacter' ARCHIVES OF MICROBIOLOGY vol. 173, 2000, pages 425 - 437, XP008155167
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).